← Back
Data updated: Mar 10, 2026
ASCENT PHARMS INC
OncologyMetabolic
ASCENT PHARMS INC is a generic drug manufacturer focused on Oncology, Metabolic. Key products include LEVOTHYROXINE SODIUM.
2015
Since
38
Drugs
-
Trials
1047
Approved (2yr)
Recent Activity
GABAPENTIN 2026-02-24
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
RIVAROXABAN 2026-02-20
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 67%
2 drugs
Metabolic 33%
1 drugs
Pipeline Strength Pro
Loading...
Active (23)
RIVAROXABAN LISDEXAMFETAMINE DIMESYLATE LUBIPROSTONE ICOSAPENT ETHYL MIRABEGRON SODIUM OXYBATE PALIPERIDONE BEXAROTENE OMEGA-3-ACID ETHYL ESTERS BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE OXYMORPHONE HYDROCHLORIDE TAMSULOSIN HYDROCHLORIDE VENLAFAXINE HYDROCHLORIDE SERTRALINE HYDROCHLORIDE MELOXICAM TOPIRAMATE LEVOTHYROXINE SODIUM FAMOTIDINE HYDROMORPHONE HYDROCHLORIDE POTASSIUM CITRATE IBUPROFEN METHYLPHENIDATE HYDROCHLORIDE METHADONE HYDROCHLORIDE
Discontinued (15)
GABAPENTIN OXYCODONE AND ACETAMINOPHEN HYDROCODONE BITARTRATE AND ACETAMINOPHEN OXYCODONE HYDROCHLORIDE BUPRENORPHINE HYDROCHLORIDE POTASSIUM CHLORIDE ESCITALOPRAM OXALATE DUTASTERIDE DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE IBUPROFEN AND FAMOTIDINE DEXMETHYLPHENIDATE HYDROCHLORIDE CARBIDOPA AND LEVODOPA GEMFIBROZIL DRONABINOL BENZONATATE
Company Info
- First Approval
- 2015-09-22
- Latest
- 2026-01-21
- Applications
- 53